PRJNA510939
Homo sapiens Epigenomics
We performed FAIRE-seq on 293-KSHV.219 cells treated with DMSO, Romidepsin, Panobinostat, or PTC-209 to observe changes in chromatin accessibility across the KSHV genome during treatment with these inhibitors.